|
SSH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84236999999365E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64859999995937E-06 |
| Normal-vs-Stage2 |
1.316820E-01 |
| Normal-vs-Stage3 |
3.988400E-02 |
| Normal-vs-Stage4 |
8.178000E-02 |
| Stage1-vs-Stage2 |
2.042400E-01 |
| Stage1-vs-Stage3 |
3.642000E-01 |
| Stage1-vs-Stage4 |
8.584400E-01 |
| Stage2-vs-Stage3 |
7.049400E-01 |
| Stage2-vs-Stage4 |
5.025400E-01 |
| Stage3-vs-Stage4 |
7.201800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.83550000004895E-06 |
| Normal-vs-AfricanAmerican |
1.622180E-03 |
| Normal-vs-Asian |
7.839900E-03 |
| Caucasian-vs-AfricanAmerican |
6.486400E-01 |
| Caucasian-vs-Asian |
6.719800E-01 |
| AfricanAmerican-vs-Asian |
7.222000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.73770000009033E-07 |
| Normal-vs-Female |
1.161640E-01 |
| Male-vs-Female |
9.535300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.337200E-03 |
| Normal-vs-Extreme_Weight |
3.71120000286496E-08 |
| Normal-vs-Obese |
5.839300E-03 |
| Normal-vs-Extreme_Obese |
7.54560000000293E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.234800E-01 |
| Normal_Weight-vs-Obese |
5.185200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.966400E-01 |
| Extreme_Weight-vs-Obese |
4.739900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.609600E-01 |
| Obese-vs-Extreme_Obese |
1.987440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.509530E-02 |
| Normal-vs-Age(41-60Yrs) |
1.363960E-03 |
| Normal-vs-Age(61-80Yrs) |
1.57320000004901E-06 |
| Normal-vs-Age(81-100Yrs) |
9.573700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.356200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.057440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.888210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.755600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.178600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.261200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.89739999956996E-07 |
| Normal-VS-Type2 PRCC |
1.551160E-04 |
| Normal-VS-KIRP CIMP |
4.605800E-02 |
| Normal-VS-Unclassified PRCC |
6.990400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.771000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.402000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.331600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.053400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.402200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.980000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.42699999986051E-07 |
| Normal-vs-N1 |
2.958400E-01 |
| Normal-vs-N2 |
4.495200E-01 |
| N0-vs-N1 |
3.293600E-02 |
| N0-vs-N2 |
1.400370E-01 |
| N1-vs-N2 |
9.841000E-01 |
|
|
